Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents in comparison to RT-qPCR, November 2020 to September 2022
Preprint
Abstract
Background: Rapid antigen detection tests (RDT) are an easily accessible, feasible, inexpensive, and point-of-care method in SARS-CoV-2 diagnostics – established in adults as well as in children and adolescents. Despite this, large-scale data of clinical performance in the paediatric population especially regarding the influence of SARS-CoV-2 virus variants of concern (VOC) and COVID-19 vaccination on test accuracy is rare. Methods: This single-centre prospective diagnostic study evaluates three RDT (NADAL®, Panbio™, MEDsan®) in comparison to quantitative reverse transcription polymerase chain reaction (RT-qPCR). 9,760 oropharyngeal screening samples regarding SARS-CoV-2 VOC and COVID-19 vaccination in paediatric hospitalised patients aged younger than 18 years were enrolled. Findings: RDT sensitivity was 44·7% (157/351, 95% CI 39·6%–50·0%) compared to the reference standard RT-qPCR, specificity 99·8% (9,392/9,409, 95% CI 99·7%–99·9%). Most SARS-CoV-2 infections considered were caused by Omicron VOC. Diagnostic accuracy of RDT depended on specimen containing viral load with a decreasing RDT sensitivity by descending viral load, corresponding with a significantly impaired sensitivity in asymptomatic children. A sensitivity of 71·0% was obtained for a viral load higher than 10 6 SARS-CoV-2 RNA copies per ml suggested as infectivity threshold. No significant differences in RDT sensitivity could be observed regarding gender, symptoms, COVID-19 vaccination status, and VOC. Interpretation: In a paediatric population, RDT have proven to reliably detect potentially highly infectious patients with a viral load of at least 10 6 SARS-CoV-2 RNA copies per ml. Due to the low sensitivity in asymptomatic individuals, the usefulness of RDT seems limited in large-scale SARS-CoV-2 screening programs. Funding: Federal Ministry for Education and Science (BMBF), Free State of BavariaKeywords
All Related Versions
- Published version: Journal of Infection, 86 (3), 256.
This publication has 21 references indexed in Scilit:
- Evaluation of a rapid antigen detection test (Panbio™ COVID‐19 Ag Rapid Test Device) as a point‐of‐care diagnostic tool for COVID‐19 in a pediatric emergency departmentJournal of Medical Virology, 2021
- Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCREBioMedicine, 2021
- Real‐life evaluation of a COVID‐19 rapid antigen detection test in hospitalized childrenJournal of Medical Virology, 2021
- Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric PopulationThe Journal of Pediatrics, 2021
- Think of the ChildrenThe Pediatric Infectious Disease Journal, 2021
- Optimal COVID-19 quarantine and testing strategiesNature Communications, 2021
- Performance and feasibility of universal PCR admission screening for SARS‐CoV‐2 in a German tertiary care hospitalJournal of Medical Virology, 2021
- Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling studyThe Lancet Public Health, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020